Q&A: A decade on, what’s next for CAR-T therapies?
Pharmaceutical Technology
APRIL 5, 2023
But access to these treatments continues to remain limited due to high price tags and variable availability across regions. The biology is different after these products are infused and demonstrating that in a product release is very complex. I think we’re at that point of these advanced therapies entering the common consciousness now.
Let's personalize your content